Clinical trial

Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar

NCT03579576

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2017-12-20

PhaseN/A

Study timeline

Study start (actual)2017-12-20Date precision: day

Registry last updated2019-07-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis Cunresolved

Hepatitis Bunresolved

HIV Infectionsunresolved

Interventions

sofosbuvir 400 mg/velpatasvir 100 mg (SOF/VEL) orally once daily for 12 weeks with or without weight-based ribavirin.DRUG

Sponsors & collaborators

Right to Carelead sponsor

Community Partners Internationalcollaborator

Myanmar Liver Foundationcollaborator

Boston Universitycollaborator

University of California, Los Angelescollaborator

Ministry of Health and Sports, Myanmarcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03579576 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.